Efficacy and safety of sacubitril/valsartan (LCZ696) in reducing adverse cardiovascular events and controlling hypertension among asians: a meta-analysis of randomised controlled trials
Event: Heart Failure 2022
Topic: Cardiovascular Pharmacotherapy
Session: Heart Failure ePosters - focus on Pharmacology and other topics
